Skip to main content
. 2012 Mar;24(1):77–82. doi: 10.1007/s11670-012-0077-z

Table 3. Correlation between the expression of HLA class I on PBMCs and clinicopathological characteristics.

        Indices HLA class I mRNA HLA class I protein
        Age (year)
            <60     0.98±0.35             119.76±28.35
            ≥60     0.90±0.28             103.71±31.26
        Gender
            Male     0.99±0.29             121.52±31.49
            Female     1.05±0.32             104.16±37.46
        Tumor size
            <2 cm     0.98±0.41              87.10±21.65
            ≥2 cm     0.89±0.39              83.76±19.29
        Lymph node metastasis
            Absent     1.01±0.26             101.30±32.69
            Present     0.78±0.35              72.91±29.18*
        TNM stage
            I     1.10±0.29              98.08±21.62
            II     0.87±0.23              89.29±27.26
            III     0.46±0.31#              61.49±18.52†
            IV     0.39±0.35#              54.61±29.81†

*P<0.05, compared with absent lymph node metastasis patients; #P<0.05, compared with stage I CRC patients; †P<0.05, compared with stage I CRC patients.